3 results
Approved WMOCompleted
Primary:* To assess the effect of vedolizumab SC maintenance treatment on clinical remission at Week 52 in subjects with moderately to severely active UC who achieved clinical response at Week 6 following administration of vedolizumab IV at Weeks 0…
Approved WMOCompleted
This trial aims to investigate if peroperative administration of TA can reduce the peroperative and postoperative hemorrhage rates in laparoscopic sleeve gastrectomy.
Approved WMORecruiting
This trial aims to investigate whether peroperative administration of TXA reduces haemorrhage rates in patients who undergo metabolic surgery.